Navigation Links
MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets

SAN DIEGO, June 15, 2012 /PRNewswire/ -- MedVantx, Inc., the company that created the first ever controlled access to generic samples in US physician offices, today highlighted it's MedStart cabinet as a solution to the problem highlighted in a recent study published in the Journal of the American Board of Family Medicine.  In the study, researchers reported that physician offices often lack the controls and tools to appropriately manage pharmaceutical samples onsite, including tracking lot number and expiration, as well as the ability to identify historical sampled patient data in the event of manufacturer product recalls.  Nearly 30% of the drug packages in one of the clinics evaluated in the study were expired.

MedVantx provides a first-of-its-kind capability for controlled access and tracking of sample medications, including generics, in US physician offices with its proprietary automated ATM-like cabinet, MedStart™.  The MedStart™ cabinet automates the traditional pharmaceutical sampling process for physicians and the MedStart Patient Profile Link™ interface captures physician sampling data in the patients' health plan electronic medical record.  Through MedStart, doctors can provide patients with generic, brand and OTC samples covering the majority of common acute and chronic conditions while the patient is in the office.  The cabinet's bar code technology automatically captures medication lot number, expiration date information and provides a web-based patient specific registry of individual physician sampling history that can be used by physicians and health systems in the event of a medication recall. 

"As the prescribing process becomes more and more technologically advanced, it's amazing that the majority of physicians' offices and health systems lack automated sample management tools and are still tracking the sample medication use process with paper, pen and clip boards," said Nicole Cardosa, MedVantx Vice President of Physician Sales.  "The fact that in this day and age, medication samples are given to patients without any integration into their online medical record is really one of the last open quality issues in the medication use process.  Physicians, health systems and payors now have the opportunity to use MedVantx patient specific sample medication data to increase patient adherence, reduce gaps in care and enhance safety."

As reported in the May-June issue of the Journal of the American Board of Family Medicine, researchers took inventories of the drug sample closets at 10 primary care clinics in the Phoenix metropolitan area. Of the 12,581 sample boxes or packages examined, 14% were expired. (

About MedVantx, Inc.

MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans, employers and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information, adherence management and reimbursement assistance; and convenient consumer home delivery through its mail order pharmacy. MedVantx has served over 3.5 million consumers through an integrated network including health plans, manufacturers and more than 3,500 prescribers.  For additional information about MedVantx visit

JD Haldeman
(858) 625-2990 ext. 130

SOURCE MedVantx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Problems Plague Medicares Method for Measuring Payment Errors
2. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
3. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
5. New Medical Device Study Offers Key Marketing Budget and Staffing Metrics to Promote Effective Use of Resources
6. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
7. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
8. Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting
9. Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers
10. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
11. Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
Post Your Comments:
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):